Is a rash on tirzepatide or semaglutide an allergic reaction?
Not from the rash alone. Labels for tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) count rash, itching and hives as possible allergic reactions. The US Zepbound label recorded allergic reactions, mostly skin ones, in 5% of users against 3% on placebo. Swelling of the lips, tongue or throat, or trouble breathing, needs emergency care.
Which rashes do the labels count as allergic?
Labels count rash, itching and hives (urticaria) as allergic reactions, and the US Zepbound label says most allergic reactions in its trials were skin reactions.14
In two Zepbound weight trials, allergic reactions (hypersensitivity) affected 5% of people on the medicine and 3% on placebo, a dummy injection.1 The EU Mounjaro product information gives 3.0% to 5.0% across its trial groups, against 1.7% to 3.8% on placebo. Its examples are hives, eczema, rash and dermatitis.4
The US Wegovy and Ozempic labels list rash and hives among reports made since the medicines went on sale.23 The placebo figures show that some people in these trials got a rash without the medicine.14
A red, itchy patch where you injected is counted separately, as an injection site reaction. The US Zepbound label recorded these in 6% to 8% of users, against 2% on placebo.1 The UK Mounjaro leaflet lists them apart from allergic reactions, and calls both common, meaning up to 1 in 10 people.7 We cover them in how long injection site reactions last.
Does the timing show whether it is allergic?
In Zepbound trials, allergic reactions within a day of a dose affected 2.1% of people on the medicine and 0.4% on placebo.1
Later reactions were closer to placebo, at 3.5% against 2.7%.1 Canada’s Zepbound monograph defines these as reactions more than 24 hours after a dose but before the next one.10 So a rash days after a dose can still be a drug reaction, but placebo users had nearly as many.1
Allergic reactions were also more common in people whose bodies made antibodies against tirzepatide, at 6.2% against 3% in those who did not.1
Which signs make it serious, and what do labels say to do?
Breathing problems, wheezing, or facial, lip, tongue or throat swelling with trouble swallowing can mean a severe allergic reaction, which UK leaflets call rare.78
Rare means up to 1 in 1,000 people.7 In Zepbound weight trials, 0.1% had a severe allergic reaction, against none on placebo.1 Anaphylaxis and angioedema (deep swelling under the skin) have been reported since tirzepatide and semaglutide went on sale.12
The US Zepbound, Wegovy and Ozempic labels tell patients to stop the medicine and seek medical advice promptly if allergic symptoms occur.123 US labels rule the medicine out after a serious reaction to it or its ingredients.12 EU, UK, Australian and Canadian labels rule it out after any allergy to the medicine or its ingredients.461012
The US labels urge caution for anyone who had anaphylaxis or angioedema on another GLP-1 medicine, because it is unknown whether they are more likely to react.12 The Mounjaro KwikPen sold in the UK and Australia contains benzyl alcohol, which those labels say may cause allergic reactions.612
What do people on GLP-1 medicines report about allergic rashes?
From public patient forums: 90 Reddit threads in r/Zepbound, r/Mounjaro, r/WegovyWeightLoss, r/Semaglutide, r/glp1 and r/WegovyPillWeightLoss, read October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Many describe hives or an itchy rash spreading well beyond the injection site, to the torso, limbs, neck or face. The US Zepbound label says most allergic reactions in trials were skin reactions such as rash and itching.1
- Matches the label Many say the rash began hours to days after a dose, often on waking. The US Zepbound label counts reactions more than a day after a dose among allergic reactions.1
- Matches the label Many describe swelling of the lips, tongue, throat, face or eyelids, sometimes as the only sign. UK leaflets list this swelling as a sign of a severe allergic reaction that needs immediate help.78
- Matches the label Several had no problem on a second GLP-1 after switching under a doctor, and several others reacted to more than one. The US labels say it is unknown whether anaphylaxis or angioedema on one GLP-1 predicts a reaction to another.12
Advice people share
- Matches the label Many say to hold the next dose and contact the prescriber first. The US Zepbound, Wegovy and Ozempic labels say to stop the medicine and seek medical advice promptly.123
- Matches the label Many suggest ruling out new foods, skincare, detergents, other medicines or infections. In Zepbound trials, 2.7% of people on placebo had a later allergic-type reaction.1
- Matches the NHS Several say to call emergency services straight away for lip, tongue or throat swelling or breathing trouble. The NHS says to call 999 for these signs.15
- Label says otherwise Several posts describe taking another dose to see what happens, or using antihistamines to keep dosing. The US labels say to stop the medicine and seek medical advice promptly if allergic symptoms occur.12
In your country
Every label we opened lists the same warning signs and says to stop and seek help; they differ on whether any allergy, or only a serious one, rules the medicine out.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: Australia’s Mounjaro and Wegovy Product Information rule the medicine out after any allergy to it or its ingredients, not only a serious one. The Mounjaro KwikPen information says its benzyl alcohol may cause allergic reactions.1213
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: Canada’s Zepbound and Wegovy monographs rule the medicine out after any allergy to it, its ingredients or its container, not only a serious one.1011
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The EU Mounjaro and Wegovy product information rule the medicine out after any allergy to it or its ingredients, not only a serious one.45
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The EU Mounjaro and Wegovy product information rule the medicine out after any allergy to it or its ingredients, not only a serious one.45
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We could not open an Indian label for this page, so this answer relies on the US, EU and UK labels.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open a Saudi label for this page, so this answer relies on the US, EU and UK labels.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open a UAE label for this page, so this answer relies on the US, EU and UK labels.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: UK product information for Mounjaro and Wegovy rules the medicine out after any allergy to it or its ingredients, not only a serious one. The Mounjaro KwikPen information says its benzyl alcohol may cause allergic reactions.69
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The US Zepbound, Wegovy and Ozempic labels rule the medicine out after a serious allergic reaction to it or its ingredients.123
Emergency number: 911
Contact your prescriber or a doctor right away if a new rash, hives or itching appears after a dose. The US Zepbound and Wegovy labels say to stop the medicine and seek medical advice promptly.12
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, sections 4, 5.6, 6.1 and 17. Eli Lilly. uspl.lilly.com
- US Wegovy (semaglutide injection and tablet) prescribing information, sections 4, 5.7, 6.2 and 17. Novo Nordisk. novo-pi.com
- US Ozempic (semaglutide injection) prescribing information, sections 4, 6.2 and 17. Novo Nordisk. novo-pi.com
- EU Mounjaro product information (SmPC), sections 4.3 and 4.8. European Medicines Agency. ema.europa.eu
- EU Wegovy product information (SmPC), section 4.3. European Medicines Agency. ema.europa.eu
- UK Mounjaro KwikPen Summary of Product Characteristics, sections 4.3 and 4.4. Electronic Medicines Compendium. medicines.org.uk
- UK Mounjaro KwikPen patient information leaflet, section 4. Electronic Medicines Compendium. medicines.org.uk
- UK Wegovy 2.4 mg FlexTouch patient information leaflet, section 4. Electronic Medicines Compendium. medicines.org.uk
- UK Wegovy 2.4 mg FlexTouch Summary of Product Characteristics, section 4.3. Electronic Medicines Compendium. medicines.org.uk
- Canadian Zepbound (tirzepatide) Product Monograph, sections 2, 7 and 8. Health Canada Drug Product Database. pdf.hres.ca
- Canadian Wegovy (semaglutide) Product Monograph, section 2. Health Canada Drug Product Database. pdf.hres.ca
- Australian Mounjaro Product Information, sections 4.3 and 4.4. Eli Lilly, via medsinfo. medsinfo.com.au
- Australian Wegovy Product Information, section 4.3. Novo Nordisk, via medsinfo. medsinfo.com.au
- Allergies and anaphylaxis. American College of Emergency Physicians. emergencyphysicians.org
- Anaphylaxis. NHS. nhs.uk
Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write